Target intelligence / Profile preview

Local inflammation

Molecular classification
Biological Process, Immune Response
01

Overview

Local inflammation is a protective response of the body's immune system to tissue injury, infection, or foreign substances occurring at a specific site. It is characterized by five cardinal signs: heat, redness, swelling, pain, and loss of function. This complex biological process involves multiple cellular components, primarily leukocytes (neutrophils, macrophages, dendritic cells, mast cells, lymphocytes) that extravasate from the bloodstream into affected tissues. It also involves numerous molecular mediators, including cytokines (e.g., TNF-α, IL-1, IL-6, IL-10), chemokines, vasoactive chemicals (e.g., prostaglandins, histamine), the complement system, reactive oxygen species (ROS), and adhesion molecules. The inflammatory process follows a sequence from initiation by DAMPs or PAMPs, through vascular responses (vasodilation, increased permeability), leukocyte recruitment, stimulus elimination, to eventual resolution and repair. It can be acute (rapid, short-term, neutrophil-dominant) or chronic (prolonged, involving mononuclear cells, potentially leading to tissue damage). While essential for host defense, dysregulation of local inflammation can contribute to various pathologies.

Other names
Inflammation
02

Mechanism of action

Drugs targeting local inflammation modulate its various components and processes. NSAIDs inhibit cyclooxygenase (COX) enzymes, reducing prostaglandin production. Corticosteroids suppress multiple inflammatory pathways. Cytokine inhibitors target specific inflammatory cytokines like TNF-α, IL-6, or IL-1 to regulate the immune response. Selective immunomodulators target specific components of the inflammatory cascade to mitigate its effects.

03

Biological functions

Protective response of the body's immune system to tissue injury, infection, or foreign substancesEliminate harmful stimuliInitiate tissue healingMechanism of innate immunity
04

Disease associations

Component of numerous diseases and conditionsInfectious DiseasesAutoimmune DisordersTrauma and InjuryChronic Inflammatory Diseases
05

Safety considerations

Can contribute to pathology when dysregulatedChronic inflammation can lead to tissue damage and fibrosis
06

Interacting drugs

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

3 more in the full profile.

07

Biomarkers

C-Reactive Protein (CRP)Erythrocyte Sedimentation Rate (ESR)Proinflammatory Cytokines (TNF-α, IL-1β, IL-6)Myeloperoxidase (MPO)

Beyond the preview

Go deeper on Local inflammation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Local inflammation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call